Skip to main contentSkip to navigation
Sirius Investors
HAVN Life Sciences Inc.

HAVN Life Sciences Inc.

HAVLF
OTCHealthcare

HAVN Life Sciences Inc. (HAVLF) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate HAVN Life Sciences Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2022
P/E Ratio
-0.40
Burn Risk
P/B Ratio
2.86
Strong
WeakModerateStrong
Earnings Yield
-2.50%
Yield Gap

Profitability Health

2022
Return on Equity
-714.55%
Weak
WeakModerateStrong
Operating Margin
-3548.44%
Weak
WeakModerateStrong
Net Profit Margin
-8117.81%
Weak
WeakModerateStrong

Growth Indicators

2022
Revenue Growth
-
No data
Net Income Growth
26.13%
Strong
WeakModerateStrong
EPS Growth
38.02%
Strong
WeakModerateStrong

Efficiency & Liquidity

2022
Current Ratio
4.51
Strong
WeakModerateStrong
Quick Ratio
2.62
Strong
WeakModerateStrong
Asset Turnover
0.07x
Weak
WeakModerateStrong
Inventory Turnover
0.16x
Weak
WeakModerateStrong

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2022
Free Cash Flow Yield
-88.79%
Weak
WeakModerateStrong
EV / Free Cash Flow
-1.04x
Strong
WeakModerateStrong
Net Debt / EBITDA
0.03x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
2.288
Strong
WeakModerateStrong
Return on Invested Capital
-2.78%
Weak
WeakModerateStrong
Cash Conversion Cycle
2038.81 days
Weak
WeakModerateStrong

Fortress screener guardrails

1/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for HAVLF.

View Financial Statements